Erchonia

Erchonia was founded in 1996 as a small family business, and even though they grown into an international corporation, they still operate under the founding principles that guided them to theirs present success. They commitment to the scientific advancement of Low Level Laser Therapy (3LT®) through clinical research has transformed Erchonia into a world leader in the field of LLLT technology. The integrity, diligence, quality and commitment of our company are evident in the rigorous scientific process we follow.

Quality Mission

They mission statement is simply “Quality Not Compromise” is engrained in every aspect of theirs business, from an unwavering belief in the limitless potential applications of low- level laser, down to the care and quality of the smallest component of their devices. Just pick up any Erchonia product and feel the quality of workmanship and see the attention to detail that can only come from Erchonia’s near-complete control of the manufacturing and assembly processes that go into each product bearing the Erchonia name.

Intellectual Property

The following list of Erchonia IP covers US patents issued, US pending patents that have reached the published for public knowledge stage of the review process, and issued US trademarks. This list does not cover the numerous pending patents in the US that have not cycled to the publishing phase and / or theirs International patents, patent pending and trademarks. Erchonia Corporation hold numerous foreign patents and trademarks, as each US filed is accompanied by application via the PCT.